Esomeprazole and omeprazole may increase the serum concentrations of benzodiazepines (by means of CYP2C19 inhibition) bringing about elevated adverse effects for example drowsiness, although the clinical relevance is reduced in most patients – monitor the affected individual for adverse effects (e. If affected person simply cannot resume their